108 related articles for article (PubMed ID: 6300582)
1. Hypotensive activity of serotonin antagonists; correlation with alpha 1-adrenoceptor and serotonin receptor blockade.
Kalkman HO; Harms YM; van Gelderen EM; Batink HD; Timmermans PB; van Zwieten PA
Life Sci; 1983 Mar; 32(13):1499-505. PubMed ID: 6300582
[TBL] [Abstract][Full Text] [Related]
2. Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats.
Kalkman HO; Engel G; Hoyer D
J Hypertens Suppl; 1984 Dec; 2(3):S143-5. PubMed ID: 6599662
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of irindalone, a new S2-serotonergic antagonist, in the rat.
Gradin K; Carlsson S; Hedner T; Persson B
Pharmacol Toxicol; 1990 Sep; 67(3):199-204. PubMed ID: 2255675
[TBL] [Abstract][Full Text] [Related]
4. An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats.
Docherty JR
J Pharmacol Exp Ther; 1989 Feb; 248(2):736-40. PubMed ID: 2537414
[TBL] [Abstract][Full Text] [Related]
5. Hypotensive properties of benzodioxane derivatives structurally related to R 28935. Comparison of activity with some receptor affinities.
Timmermans PB; Slothorst-Grisdijk FP; van Kemenade JE; Schoop AM; Batink HD; van Zwieten PA
Arch Int Pharmacodyn Ther; 1982 Feb; 255(2):321-34. PubMed ID: 6280629
[TBL] [Abstract][Full Text] [Related]
6. Effects of antagonists of 5-hydroxytryptamine on blood pressure in the anesthetised spontaneously hypertensive rat.
Docherty JR; Warnock P
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S59-61. PubMed ID: 2446073
[TBL] [Abstract][Full Text] [Related]
7. Selectivity of benzodioxane alpha-adrenoceptor antagonists for alpha 1- and alpha 2-adrenoceptors determined by binding affinity.
Timmermans PB; van Kemenade JE; Batink HD; van Zwieten PA
Pharmacology; 1983; 26(5):258-69. PubMed ID: 6134295
[TBL] [Abstract][Full Text] [Related]
8. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
9. [3H]ketanserin labels 5-HT2 receptors and alpha 1-adrenoceptors in human and pig brain membranes.
Hoyer D; Vos P; Closse A; Pazos A; Palacios JM; Davies H
Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):226-30. PubMed ID: 2884572
[TBL] [Abstract][Full Text] [Related]
10. Studies on the mechanism of action of the hypotensive effect of ketanserin.
Marwood JF; Stokes GS
Clin Exp Pharmacol Physiol; 1984; 11(2):125-32. PubMed ID: 6086191
[TBL] [Abstract][Full Text] [Related]
11. Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat.
McDaid J; Docherty JR
Br J Pharmacol; 2001 Jun; 133(3):429-37. PubMed ID: 11375260
[TBL] [Abstract][Full Text] [Related]
12. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Titeler M; Lyon RA; Davis KH; Glennon RA
Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
[TBL] [Abstract][Full Text] [Related]
13. Characterization of flufylline, fluprofylline, ritanserin, butanserin and R 56413 with respect to in-vivo alpha 1-,alpha 2- and 5-HT2-receptor antagonism and in-vitro affinity for alpha 1-,alpha 2- and 5-HT2-receptors: comparison with ketanserin.
Korstanje C; Sprenkels R; Doods HN; Hugtenburg JG; Boddeke E; Batink HD; Thoolen MJ; Van Zwieten PA
J Pharm Pharmacol; 1986 May; 38(5):374-9. PubMed ID: 2872314
[TBL] [Abstract][Full Text] [Related]
14. Distinction between adrenergic and serotonergic receptor subtypes: specificity of drugs and absence of cooperative interactions between adrenergic and serotonergic receptor binding sites.
Leysen JE; Van Gompel P; Gommeren W
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S78-87. PubMed ID: 2459521
[TBL] [Abstract][Full Text] [Related]
15. Antagonistic effects of some metabolites and analogues of mianserin on serotonin and alpha 1- and alpha 2-adrenergic receptors in the flexor reflex model in vivo.
Przegaliński E; Rawłów A; Dohnal-Borak I
Pol J Pharmacol Pharm; 1986; 38(1):69-75. PubMed ID: 3020532
[TBL] [Abstract][Full Text] [Related]
16. Hypotensive effects of eugenosedin-A with serotonin, alpha- and beta-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats.
Shen KP; Chiu CC; Chen SJ; Chen IJ; Wu BN
Pharmacology; 2004 Jun; 71(2):91-101. PubMed ID: 15118348
[TBL] [Abstract][Full Text] [Related]
17. Effects of bunitrolol on adrenergic and serotonergic receptors.
Tsuchihashi H; Aono J; Nagatomo T; Kawada T; Ohta H; Imai S
Jpn J Pharmacol; 1987 Nov; 45(3):349-56. PubMed ID: 2893855
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the affinity for [3H]mianserin-labelled receptors in brain and antagonism of the serotonin pressor response in pithed rats.
Kalkman HO; Batink HD; Thoolen MJ; Timmermans PB; van Zwieten PA
Biochem Pharmacol; 1983 Jul; 32(13):2111-3. PubMed ID: 6870938
[No Abstract] [Full Text] [Related]
19. Study of the in vivo and in vitro cardiovascular effects of four new analogues of ketanserin: implication of 5-HT2A and alpha1 adrenergic antagonism in their hypotensive effect.
Orallo F; Tristan H; Garcia-Ferreiro T; De Francisco S; Masaguer C; Raviña E; Calleja JM; Cadavid I; Loza MI
Biol Pharm Bull; 2000 May; 23(5):558-65. PubMed ID: 10823664
[TBL] [Abstract][Full Text] [Related]
20. Serotonin (5HT) and its antagonists: involvement in the cardiovascular system.
Marwood JF; Stokes GS
Clin Exp Pharmacol Physiol; 1984; 11(5):439-55. PubMed ID: 6098391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
